Nabriva Therapeutics Reports Second Quarter 2017 Financial Results and Recent Corporate Highlights
Aug 07, 2017 11:00 am UTC| Business
DUBLIN, Ireland, Aug. 07, 2017 -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical-stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections,...
Destination XL Group, Inc. to Announce Second Quarter 2017 Financial Results on August 24, 2017
Aug 07, 2017 11:00 am UTC| Business
CANTON, Mass., Aug. 07, 2017 -- Destination XL Group, Inc. (NASDAQ:DXLG), the largest omni-channel specialty retailer of big tall men's apparel, announced today it will release its second quarter fiscal 2017 financial...
II-VI Incorporated Reports Fiscal 2017 Fourth Quarter and Full Year Earnings
Aug 07, 2017 10:55 am UTC| Business
Record Fourth Quarter and Full Year RevenueRecord Full Year Bookings Exceed $1.0 Billion PITTSBURGH, Aug. 07, 2017 -- II-VI Incorporated (Nasdaq:IIVI) ("II-VI" or the "Company") today reported results for its fiscal...
Coolisys Technologies Announces Acquisition of Power-Plus Technical Distributors
Aug 07, 2017 10:50 am UTC| Business
FREMONT, Calif., Aug. 07, 2017 -- Digital Power Corporation (NYSE MKT:DPW) ("Digital Power" or the "Company"), a company seeking to increase revenues through acquisitions and organic growth, today announced that its...
II-VI Incorporated Acquires Kaiam’s 6-inch Wafer Fabrication Facility in the U.K.
Aug 07, 2017 10:50 am UTC| Business
300,000 square foot facility with a 100,000 square foot clean room near Newcastle, U.K.GaAs, SiC and InP devices capabilitiesPurchase price of the acquisition was $80 million in cash PITTSBURGH, Aug. 07,...
CONE Midstream Reports Second Quarter Results
Aug 07, 2017 10:45 am UTC| Business
CANONSBURG, Pa., Aug. 07, 2017 -- CONE Midstream Partners LP (NYSE:CNNX) ("CONE Midstream" or the "Partnership") today reported financial and operational results for the three months ended June 30, 2017(1). Second...
Aug 07, 2017 10:45 am UTC| Business
DEVON, Pa., Aug. 07, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal pharmaceutically-produced...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects